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ABSTRACT
Objective To evaluate the cost-effectiveness of
distribution of the integrated neonatal care kit (iNCK) by
community health workers from the healthcare payer
perspective in Rahimyar Khan, Pakistan.
Setting Rahimyar Khan, Pakistan.
Participants N/A.
Intervention Cost-utility analysis using a Markov model
based on cluster randomised controlled trial (cRCT: NCT
02130856) data and a literature review. We compared
distribution of the iNCK to pregnant mothers to local
standard of care and followed infants over a lifetime
horizon.
Primary and secondary outcome measures The
primary outcome was incremental net monetary benefit
(INMB, at a cost-effectiveness threshold of US$15.50),
discounted at 3%. Secondary outcomes were life years,
disability-adjusted life years (DALYs) and costs.
Results At a cost-effectiveness threshold of US$15.50,
distribution of the iNCK resulted in lower expected DALYs
(28.7 vs 29.6 years) at lower expected cost (US$52.50
vs 55.20), translating to an INMB of US$10.22 per iNCK
distributed. These results were sensitive to the baseline
risk of infection, cost of the iNCK and the estimated effect
of the iNCK on the relative risk of infection. At relative risks
of infection below 0.79 and iNCK costs below US$25.90,
the iNCK remained cost-effective compared with current
local standard of care.
Conclusion The distribution of the iNCK dominated the
current local standard of care (ie, the iNCK is less costly
and more effective than current care standards). Most of
the cost-effectiveness of the iNCK was attributable to a
reduction in neonatal infection.

INTRODUCTION
Neonatal mortality is the primary contributor to death among children under 5,
with one-
third of these deaths attributable
to infection.1 With 46 neonatal deaths per
1000 live births, Pakistan has the highest
neonatal mortality rate (NMR) in the world.1
Randomised controlled trials (RCTs) and
pooled analyses in other countries have
demonstrated the efficacy of several strategies

Strengths and limitations of this study
► This study is the first cost-effectiveness analysis us-

ing empiric randomised controlled trial data to evaluate a bundle of newborn interventions (integrated
neonatal care kit, iNCK) in comparison to local standard of care.
► This cost-effectiveness analysis would be improved
by additional empiric data describing the effect of
iNCK use on maternal mortality and the detection
and management of neonatal hypothermia.
► Further study is needed to evaluate the association
between iNCK compliance (eg, correct use of individual kit components) and risk of neonatal infection
and other key health outcomes including mortality.

to reduce neonatal mortality including: use
of a clean birth kit (CBK) (OR: 0.52, 95% CI:
0.39 to 0.68),2 use of chlorhexidine for cord
cleansing (relative risk (RR): 0.77, 95 % CI:
0.63 to 0.94),3 oil-based skin emollient application to prevent hypothermia and preserve
the skin barrier reducing infection (RR:
0.73, 95% CI: 0.56 to 0.94)4 and community
interventions to improve clean birth practices to reduce NMRs (RR: 0.52, 95% CI:
0.39 to 0.68).2 Despite evidence to support
several clean birth care practices, their use
in Pakistan is variable. In a recent survey
of 225 mothers following delivery in Sindh
province, only 32% of those who delivered
at home reported use of a clean delivery kit
(new blade, sterilised disposable gloves, soap,
gauze, cotton balls, antiseptic solution, umbilical cord clamp and polythene sheet), 24% of
women reported use of cord antiseptics and
45% reported cutting the cord with a sterile
blade.5 Other reported practices include
application of skin emollients (ghee, mustard
oil and lotion) and substances applied to
the cord (turmeric, ghee, surma and oil).6
Individual financial constraints, difficulty
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accessing CBKs, antiseptic solution and emollients and
cultural beliefs hinder the widespread uptake of these
potentially life-saving interventions.7
While the efficacy of individual interventions has been
demonstrated, the effectiveness of combined interventions remains unclear. In addition, the effectiveness of
combined kit components, implemented in community-
based settings and delivered entirely by community health
workers, remained largely unstudied. Recently, a cluster
RCT (cRCT: NCT 02130856) was conducted in rural Pakistan to evaluate the effect of distribution of an integrated
neonatal care kit (iNCK) by community Lady Health
Workers (LHWs) on neonatal health outcomes.6 8 LHWs
are government-funded, trained community healthcare
providers who are each responsible for family planning
and primary healthcare services for 150–200 homes.
LHWs provide basic reproductive, maternal, newborn
and child health education, basic curative care and are
trained to identify neonatal danger signs and recommend referral.6 While LHWs do not attend births directly,
promotion of clean birth practices, use of skilled birth
attendants and timely referral to emergency obstetric or
neonatal care are an integral part of their role in Pakistan.9 The iNCK contained a CBK (gloves, soap, clean
plastic sheet, sterile blade and cord clamps), 4% chlorhexidine solution, sunflower oil emollient, a continuous
temperature monitor sticker, a blanket and an instant
heat pack. In addition, during the cRCT, a weighing
scale was distributed to LHWs to enable them to screen
newborn infants for low birth weight.6 Neonatal mortality
was not significantly different between treatment groups
(risk ratio: 0.83, 95% CI: 0.58 to 1.18; p=0.30). However,
the risk of omphalitis, irrespective of severity, was 32%
lower in the intervention arm compared with the control
arm (RR: 0.68, 95% CI: 0.48 to 0.98; p=0.04).6
We aimed to assess the cost-effectiveness of distribution
of an iNCK by LHWs to pregnant mothers compared with
local standard of care in rural Pakistan from a governmental healthcare payer perspective. Distribution of an
iNCK by LHWs, financed by the government healthcare
payer, may contribute to circumventing barriers to uptake
of clean birth practices.
METHODS
We conducted a model-based cost-effectiveness analysis of
iNCK distribution by LHWs compared with the current
standard of care in rural Pakistan from the perspective
of the governmental healthcare payer. The governmental
payer perspective was used to inform whether the cost of
widespread iNCK distribution financed by the government would be cost-effective due to improved neonatal
outcomes and associated decreased healthcare utilisation
costs to the government payer.
Trial design, eligibility criteria and study procedures
for the LHWs and the family members have been fully
described previously.6 10 In brief, all women in the third
trimester of pregnancy within participating randomised

clusters were considered eligible if they intended to stay
in the study catchment area for at least 1 month after
delivery. Participating LHWs identified pregnant women
and notified the study team. A data collector visited pregnant women, explained the study and obtained written
informed consent. The LHW delivered the iNCK and/or
the standard of care. All participants had agency to opt
out of the study at any time and for any reason.
based anteStandard of care, included community-
natal and postnatal care by LHWs and may or may not
have included the use of other clean birth practices.
Standard antenatal care by LHWs (in both groups of the
cRCT) includes delivery of basic reproductive, maternal,
newborn and child health education, promotion of
healthy behaviour, basic curative care and identification
of neonatal danger signs and referrals as appropriate.6
Several alternative clean birth and newborn interventions
were used in the cRCT comparator group, which were
summarised in the model as use of any CBK and/or a
cord antiseptic (Dettol). In the cRCT comparator arm,
50.3% used any CBK and 60.7% used a cord antiseptic.6
For the purposes of the iNCK intervention, LHWs were
additionally instructed on the use of the kit, the weighing
scale, application of chlorhexidine to the umbilicus, education of sunflower oil emollient massage for the newborn
and use of the thermal pack. At the time of delivery,
LHWs taught mothers how to use each iNCK component
and, if present, other caregivers were engaged in the
teaching session. Pregnant women were taught to apply
chlorhexidine to the umbilical stump once daily from day
1 to day 10, and to apply one ThermoSpot sticker to the
skin over the carotid artery on day 1 and leave it in place
until day 14. Women were taught the meaning of each
sticker colour and the actions to be taken if ThermoSpot
indicated fever, cold stress or hypothermia. Sunflower oil
was to be massaged over the newborn’s body once daily
starting from day 3 until day 28.
Costs associated with the iNCK, hospitalisation or
outpatient treatment for infection and the treatment for
long-term sequelae were included. Given that significant
sequelae from neonatal sepsis can have lifelong effects, a
lifetime time horizon was selected. A 3% discount rate was
applied to life years, DALYs and costs, as recommended
by the WHO.11
The cost-
effectiveness threshold (CET) was set at
US$15.50 per DALY, corresponding to 1% of Pakistan’s
GDP per capita in 2019, a conservative estimate of health
spending.12 Though the WHO recommends a CET equivalent to a country’s GDP per capita, this is perceived as
controversial for low-income and middle-income countries (LMICs).8 13 14 Published estimates of CETs range
from 1% to 59% GDP per capita in LMICs due to low
healthcare spending.8 13 14
Primary outcomes were disability-
adjusted life years
(DALYs), total costs and incremental net monetary
benefit (INMB; CET of US$15.50).8 DALYs were selected
as a standardised measure of cost-effectiveness as recommended by the WHO, National Institute of Health and
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Figure 1 Model schematic diagram. (A) Markov Health State Transition Diagram. A child can be born at home or facility and
then proceed to either the states of long-term sequelae (LTS), well or death. Stillbirth infants are accounted for in the death
absorbing state. (B) Tree diagram after birth. At birth, a child can either be in the cohort to which an iNCK was distributed or
not. In the intervention arm, the elements of the iNCK may be used or not. Similarly, in the control arm, other clean birth and
newborn care strategies may or may not be used. The neonate may develop an infection which could either be severe infection
or omphalitis (mild/moderate cord infection). If they develop a cord infection, they may go on to develop a severe infection.
In the presence of infection, they may be hospitalised or receive outpatient care and proceed to either the death, well or
LTS states. If they have no infection, they proceed to the well state. At any point, they can die from unrelated causes. iNCK,
integrated neonatal care kit.

Bill and Melinda Gates Foundation. Secondary outcome
was life years.
Model structure
A Markov cohort model was developed (figure 1) using
TreeAgePro 2018 software (V.2020 r 1.2, Grey Matter,
England). Health outcomes and cost were modelled
over a lifetime time horizon in 1-year time steps (ie, cycle
length in a Markov model) to encapsulate the neonatal
infections and sequelae occurring in the first 28 days of
life, the risk of all-cause mortality within 1 year of age
and thereafter to model the impact of sequelae over
the lifetime time horizon. The initial health states were
either birth at home or facility, accounting for stillbirths.
Liveborn neonates were followed over time for development of a neonatal infection, categorised as omphalitis
(cord infection) or severe infection. It was assumed that
Muttalib F, et al. BMJ Open 2022;12:e047793. doi:10.1136/bmjopen-2020-047793

infants who had both cord infection and severe infection
developed the cord infection first followed by secondary
severe infection. Causes of neonatal infection other than
omphalitis (eg, pneumonia, sepsis) were grouped under
severe infection. Neonatal infection was assumed to have
occurred only once. It was also assumed that all children
with severe infection who did not receive hospital care
received outpatient therapy. At the end of the first year,
all live born infants have lived 1 year and transitioned to
one of three health states: well, death due to infection,
survival with severe neurodevelopmental or learning
impairment, with or without CP. The probability of all-
cause mortality at 1 year was accounted for.
Model data
Data to inform the model were primarily drawn from
the iNCK cRCT in which clusters were randomised to
3
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receive either the iNCK or local standard of care. This was
supplemented by a comprehensive literature review, local
data sources and expert opinion. All variables and their
supporting references are summarised in table 1. The
cRCT data provided probabilities for location of delivery
(home vs facility), reported use of a CBK and/or cord
antiseptic (presumed iNCK CBK in the intervention arm
or other CBK with or without Dettol cord antiseptic in
the control arm), baseline risk of any infection or omphalitis and RR of severe infection stratified by delivery location and reported use of a CBK and/or cord antiseptic
(presumed iNCK in the intervention arm or other CBK
with or without Dettol cord antiseptic in the control
arm). Severe infection was a priori defined in the cRCT
as the presence of any of: seizures, fast respiratory rate
(60 breaths/min or more), fever, severe chest in drawing,
poor feeding and abnormal activity.15 In a post-hoc sensitivity analysis, poor feeding and/or abnormal activity,
which were reported at higher than anticipated rates,
were removed from the initial definition of severe infection. In the cost-effectiveness model, the revised post-hoc
definition of severe infection was applied to use a more
specific case definition and exclude symptoms that may
represent other causes of illness than infection. The probability of severe infection using the revised definition was
not stratified according to whether mothers reported use
of a CBK.
We assumed that published data from studies conducted
in Pakistan were representative of our study population.
Variables drawn from the literature included probability
of hospitalisation given severe infection, probability of
death due to severe infection given treatment in hospital,
probability of severe neurodevelopmental impairment
(NDI, with or without CP) following severe infection and
annual probability of death. The probabilities of sequelae
of neonatal severe infection were drawn from an international meta-
analysis of studies in LMICs evaluating
neonatal outcomes after sepsis among hospitalised low
birth weight infants.16 The annual mortality rate (AMR)
for severe mental retardation in Pakistan was used as a
proxy for AMR among patients with severe NDI given that
data specific to NDI were not available.17 Data for three
variables (probability of hospitalisation if mild/moderate
omphalitis, probability of mild/moderate omphalitis to
severe and RR of death due to severe infection if not
hospitalised) could not be obtained from the literature
or cRCT data, thus were based on paediatric infectious
diseases and paediatric critical care expert opinions
(Morris and Muttalib, personal communication, 2018).
The effect of compliance of appropriate use of the iNCK
on risk of infection was not modelled.
Health-
related utilities (DALYs) were designated for
the death state (disability weight (DW) of 1), the long-
term sequelae state (DW for CP) and the well state (DW
of 0). There is no published DW for mild/moderate
omphalitis in neonates, thus a weighted average of the
total proportion of mild omphalitis and moderate omphalitis was multiplied by the respective DWs for acute mild

infection and acute moderate infection from the Global
Burden of Disease Study.18 This was a one-time toll for
the affected cohort. The remaining DWs (neonatal sepsis,
CP) were from the Iran Burden of Disease Study19 and the
Dutch Burden of Disease study,20 given that these were
the only weights available and were previously used for
an economic evaluation of neonatal sepsis in sub-Saharan
Africa.21
All costs in foreign dollars were converted to US Dollars
(US$) using OECD Purchasing Power Parity and inflated
using the American Healthcare Consumer Price Index to
present-day dollars in 2019.22 US$ was chosen as it is the
international dollar currency recognised by both government and non-governmental healthcare payers. The base
case cost of the iNCK for distribution and biannual training
for LHWs used in the model was US$10.25. The range of
costs used for sensitivity analysis was based on the quoted
estimate for mass distribution and production of the iNCK
with LHW training (US$5) and initial start-up maximal
costs (US$200).6 Cost data for omphalitis-related hospital
stay and outpatient care was obtained from the WHO.16
Cost for outpatient antibiotics were provided by the Pakistan Drug Regional Authority, a Pakistan pharmacy source
and a cross-sectional study of 1083 newborns with omphalitis in Karachi, Pakistan.23–25 Treatment costs for mild/
moderate omphalitis included antibiotic costs and either
outpatient or hospitalisation costs for a 7-day treatment
of a 4 kg neonate.23–25 We did not assign a cost for standard care as we assumed that there would be no cost to the
healthcare payer for interventions purchased privately by
pregnant mothers. The cost of long-term sequelae to the
healthcare payer was assumed to be 0 as these costs would
be borne primarily by families. Finally, the only reported
cost of outpatient treatment was in urban Pakistan and
assumed to be the same for rural Pakistan.26
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Patient and public involvement
Patients or the public were not involved in the design,
or conduct, or reporting, or dissemination plans of our
research.
Analysis
Base case analysis
The base case analysed assessed distribution of the iNCK
to pregnant mothers at a cost of US$10.25 per kit with a
CET of US$15.50 in comparison to standard care.
Sensitivity analyses
Deterministic sensitivity analyses were performed to assess
parameter uncertainty and to identify threshold values for
which the dominating strategy changed. Ranges for one-
way sensitivity analysis were based on published literature
or expert opinion. Variables with the greatest impact on
the INMB in the one-way sensitivity analysis were assessed
in the two-way sensitivity analysis.
Validation
Two programmers (KC and FM) screened the model
for errors through manual review and using one-
way
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Table 1 Probabilities, costs and disability-adjusted life years used in the iNCK model
iNCK distribution

Standard care

References

Home delivery Facility delivery Home delivery Facility delivery
Probabilities
 Delivery site

0.40

0.60

0.39

0.61

Pell et al6

 Use of iNCK (intervention) or
standard of care (control)

0.95

0.90

0.18

0.72

Pell et al6

 Any neonatal infection

0.15

 Relative risk of any neonatal
infection given use of kit

0.55

0.73

1.17

0.93

Pell et al6

 Relative risk of any neonatal
infection given no use of any
kit

0.96

0.92

0.96

0.92

Pell et al6

 Severe infection given any
infection and use of a kit

0.57

0.46

Pell et al6

 Severe infection given any
infection and no use of a kit

0.57

0.54

Pell et al6

 Severe omphalitis given any
omphalitis and use of a kit

0.47

0.39

0.29

0.35

 Pell et al6

 Severe omphalitis given any
omphalitis and no use of a kit

0.47

0.39

0.32

0

 Pell et al6

 Mild/moderate omphalitis
progressing to severe
omphalitis

0.13

Muttalib and
Morris, personal
communication, 2018

 Hospitalisation if omphalitis

0.10

Muttalib and
Morris, personal
communication, 2018

 Hospitalisation if severe
infection

0.50

0.57

0.50

0.57

Pell et al6

 Death from sepsis given
hospitalisation

0.33

0.22

0.33

0.22

Bhutta and Yusuf31

 Death from sepsis given no
hospitalisation

0.90

Muttalib and
Morris, personal
communication, 2018

 Long-term sequelae

0.19

Ranjeva et al21

 Death (annually)
 Death due to long-term
sequelae annually

Pell et al6

0.001–0.23

WHO Life tables—
Pakistan 2018
Yaqoob et al17

0.36

Costs (US$, 2018)
 Cost of LHW training per kit
distributed
 Cost of the iNCK

0.25

0

Muhammad
et al, personal
communication, 2019

10.00

0

Pell et al6

 Cost of hospitalisation for
sepsis

972.41

Hussain et al 2006

 Cost of hospitalisation for
omphalitis

192.52

WHO Pakistan, 2005

 Cost of outpatient therapy
(7 days)

 

 Cephalexin

16.42

Qamar et al24

 Gentamicin
 Penicillin

0.45
1.50

Qamar et al24
Qamar et al24
Continued
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Table 1 Continued
iNCK distribution

Standard care

References

Home delivery Facility delivery Home delivery Facility delivery
 Outpatient clinic visit

55.23

WHO Pakistan25

 Total cost of outpatient
therapy

73.60

 

Health-related disability weights
 Cerebral palsy

0.17

Mathers et al26

 Neurodevelopmental
impairment

0.22

Ranjeva et al21

 Sepsis
 Mild/moderate infection

0.61
0.01

Naghavi et al19
Salomon et al18

iNCK, integrated neonatal care kit; LHW, Lady Health Workers.

sensitivity analysis of all variables. Face validity was verified through review by a content expert (SKM). Validating this model with goodness-of-fit measures was not
possible given that existing research evaluations varied
based on perspective,27 28 time horizon,28 intervention,29
analysis27–30 and outcome,28 29 or a combination of these
variables. Overall, these interventions were reported to be
cost-effective based on their respective CETs, which was
consistent with our results.27–30
RESULTS
Model parameters are illustrated in table 1.
Base case
Distributing the iNCK dominated the current standard
of care because it is more effective and less costly, with
lower expected DALYs (28.7 vs 29.6 years) at a lower cost
(US$52.50 vs 55.20) per iNCK distributed, resulting in an
INMB of US$10.22 at a CET of US$15.50.
These results were sensitive to the cost of the iNCK,
baseline risk of infection and the estimated effect of the
iNCK on the RR of infection (figures 2 and 3). As the baseline risk of infection increased, INMB associated with the
intervention increased. The iNCK remained cost-effective
for any iNCK cost up to US$25.90 (base case US$10.25).
A two-way sensitivity analysis of iNCK cost and estimated
effect of the iNCK on the RR of infection shows the dominance of iNCK (figure 2). As the estimated effect of the
iNCK on the risk of infection decreases (up to RR 0.79),
the cost of the iNCK must also decrease for the iNCK to
remain cost-effective.

the iNCK remained cost-effective. As the cost of the kit
increased (up to US$105), a greater relative reduction in
risk of infection (RR<0.79) was required for the iNCK to
remain cost-effective. Thus, mass production of iNCK at a
low cost and/or improving the effectiveness of the iNCK
in reducing infection would be beneficial for the healthcare payer.
The main driver of cost-effectiveness in our model was
reduction in risk of neonatal infection through use of the
iNCK. This depended on a definition of severe infection
revised by the cRCT authors in sensitivity analysis to optimise specificity. In a sensitivity analysis including the original definition of severe infection in the model, the iNCK

DISCUSSION
The iNCK was cost-effective compared with the current
standard of care (INMB of US$10.22 at a CET of
US$15.5). These results were most sensitive to the cost
of the iNCK, baseline risk of neonatal infection and
the RR of infection associated with use of the iNCK. At
iNCK costs up to US$25.91 or RR of infection below 0.79,

Figure 2 Two-way sensitivity analysis of iNCK cost versus
relative risk of infection. The blue-coloured region represents
ranges of the variables for which the intervention dominates,
whereas the red-coloured region represents ranges of the
variables for which standard care dominates. We note that
as the estimated effect of the iNCK on the relative risk of
infection decreases, a larger range of iNCK costs remain
cost-effective. Similarly, as the cost of the iNCK decreases, a
lesser reduction in relative risk of infection is required for the
intervention to remain cost-effective. Base case values (RR:
0.66, cost US$10.25) are illustrated by the dotted lines. iNCK,
integrated neonatal care kit; RR, relative risk.
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-200

-150

-100

-50

0

50

100

150

Cost of iNCK 10.25 (5 - 200)

Relative risk of infection with iNCK use intervention 0.66 (0.25 - 1)

Probability of infection 0.14 (0.1 - 0.8)

Probability of hospitalization 0.5 (0.25 - 0.6)
EV 10.22

Figure 3 Tornado diagram of the impact of probabilities and costs on Incremental Net Monetary Benefit Comparing the
Intervention to Standard Care. The X-axis represents the range of incremental net monetary benefit (INMB) when probabilities
and costs are varied over the range displayed on the Y-axis at a cost-effectiveness threshold of US$15.50. The base case is
represented by the vertical line with an INMB of US$10.22. Green bars represent increasing variable value above the base case
value, orange bars represent decreasing variable value below the base case value. The model is most sensitive to the cost of
the iNCK, baseline probability of infection and relative risk of infection. iNCK, integrated neonatal care kit; EV: Expected Value

was not cost-effective. The revised definition excluded
the following variables: presence of abnormal activity and
poor feeding. We elected to use this definition in our
model as we aimed to capture the specific probability of
severe infection while abnormal feeding and behaviour
might reflect other non-specific causes of illness in the
neonatal period, in particular when self-
reported by
caregivers rather than being observed by medical professionals. Retrospective recall by caregivers may have led
to overidentification of possible severe infection in the
cRCT using the abnormal feeding and behaviour criteria.
The broad definition of severe infection was intended
for high-sensitivity detection of illness in a community
setting and not for specific identification of severe infection cases. For these reasons, the revised definition was
retained in the final model. The lack of data in the cRCT
including laboratory confirmation of serious bacterial
infection or healthcare provider assessment of signs of
possible serious bacterial infection are important limitations that must be addressed in future studies to inform
cost-effectiveness analysis.
The most significant limitation of our model was lack of
primary data and reliance on other published literature.
Due to this limitation, our model may underestimate
the cost-effectiveness of the intervention. For example,
although the iNCK included tools for temperature monitoring and warming, we were not able to capture whether
this contributed to improved neonatal outcomes. Similarly, clean birth practices may reduce the incidence of
maternal infection and mortality; however, we could not
evaluate the impact of iNCK use on maternal outcomes.
Evidence of reduction in maternal sepsis-related morbidity
and mortality as well as improved neonatal hypothermia
detection and management would make the iNCK more
Muttalib F, et al. BMJ Open 2022;12:e047793. doi:10.1136/bmjopen-2020-047793

cost-effective. Finally, we were not able to evaluate whether
correct use of the iNCK components was associated with
greater cost-
effectiveness. Based on a post-
hoc definition, perfect compliance to all individual iNCK elements
was 2%–3% within the intervention cohort.6 We lacked
data regarding how rates of infection may have differed
between those with complete compliance compared with
those with incomplete compliance to iNCK elements.
While this likely represents real-world cost-effectiveness
of the intervention, further study to evaluate the impact
of compliance on risk of infection is needed. This would
allow for additional sensitivity analyses to be conducted to
determine how strategies to improve kit compliance may
impact cost-effectiveness of the iNCK.
Additional data limitations did not result in significant
effects on the cost-effectiveness of the intervention in sensitivity analysis. These included infection-
specific mortality
rates and costing data. First, infection-specific mortality rates
were drawn from neonatal sepsis literature in urban Pakistan,
not rural Pakistan.31 While probability of death due to infection may be different in a rural setting, our model was not
sensitive to a wide range of infection-specific mortality rates.
Second, there were limitations in the published literature
regarding cost data for LMICs. Although, wherever possible,
we did use data from Pakistan, all of these data (cost of hospitalisation, cost of outpatient care) were from urban Pakistan.
The cost of medications was based on weight of a 4 kg term
neonate, which is likely an overestimate of average neonatal
weight in Pakistan. Our model was not sensitive to a range of
outpatient medication costs including zero, therefore costs
associated with pursuing outpatient care were not a driver of
cost-effectiveness in this model.
Our study findings require further validation to ensure
generalisability. We assumed the use of existing healthcare
7
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infrastructure and the LHW system to deploy the iNCK,
increasing feasibility and limiting implementation costs.
Thus, this cost-effectiveness study may not be generalisable
to contexts without an established community health worker
system. In addition, we assumed that healthcare was sought
for all infants with infection. Data regarding healthcare-
seeking behaviour and probability of hospitalisation were
drawn from literature specific to Pakistan but included both
rural and urban populations. Due to specific cultural beliefs
and geographical constraints, barriers to seeking healthcare
may be heterogeneous within a country and care-seeking in
a rural setting may be diminished. If the number of infants
who received care for infection was overestimated by our
model, either in-hospital or as outpatients, the estimation of
treatment-related costs would be excessive while infection-
related mortality would be underestimated. We did not
model the possibility that patients received no therapy at all
given lack of available data; however, the probability of hospitalisation did not modify the cost-effectiveness of the iNCK
in one-way sensitivity analysis. We relied on face validity with
content experts to assess the accuracy of literature estimates.
Finally, we were unable to account for the effect of participation in a RCT in the control group on frequency of use
of clean birth strategies, choice of location of delivery and
surveillance for infection. It is well known that the Hawthorne
effect32 may impact the behaviour of enrolled participants, in
this case biasing the control group towards use of clean birth
strategies and decreased risk of infection. The iNCK was cost-
effective despite frequent use of clean birth strategies in the
standard care cohort. Thus, the benefit would likely be even
greater in settings where clean birth practices are lacking.
With consideration of the stated limitations, our analysis indicates that distribution of the iNCK by LHWs in
rural Pakistan is cost-effective at a conservative CET. These
results are in keeping with published studies evaluating the
cost-effectiveness of various clean birth strategies.27 28 30 The
cost per DALY averted for our base case was US$74 which
compares favourably to other cost-
effective interventions,
such as rotavirus immunisation which is estimated to cost
US$186 per DALY averted in South East Asia.33
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